Congenital Kaposiform Hemangioendothelioma with Kasabach–Merritt Phenomenon Successfully Treated with Low‐Dose Radiation Therapy | Zendy

Malhotra Yogangi | Zendy; Yang Catherine S. | Zendy; McNamara Joseph | Zendy; Antaya Richard J. | Zendy

Premium

Congenital Kaposiform Hemangioendothelioma with Kasabach–Merritt Phenomenon Successfully Treated with Low‐Dose Radiation Therapy

Author(s) -

Malhotra Yogangi,

Yang Catherine S.,

McNamara Joseph,

Antaya Richard J.

Publication year - 2013

Publication title -

pediatric dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 73

eISSN - 1525-1470

pISSN - 0736-8046

DOI - 10.1111/pde.12090

Subject(s) - medicine , kasabach–merritt syndrome , radiation therapy , hemangioendothelioma , chemotherapy , consumptive coagulopathy , dermatology , surgery , radiology , hemangioma , coagulopathy

Kaposiform hemangioendothelioma (KHE) associated with Kasabach–Merritt phenomenon is a life‐threatening vasculopathy. The current mainstay treatment for KHEs is corticosteroids and chemotherapy, but these medications do not work for all patients and carry significant side effects. We report a neonate with a large congenital KHE who responded extremely well to low‐dose radiation therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research